Based on the Aster DM Healthcare Limited stock forecast from 0 analysts, the average analyst target price for Aster DM Healthcare Limited is not available over the next 12 months. Aster DM Healthcare Limited’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Aster DM Healthcare Limited is Neutral, which is based on 5 positive signals and 5 negative signals. At the last closing, Aster DM Healthcare Limited’s stock price was INR 366.00. Aster DM Healthcare Limited’s stock price has changed by -29.86% over the past week, -16.56% over the past month and +46.96% over the last year.
No recent analyst target price found for Aster DM Healthcare Limited
No recent average analyst rating found for Aster DM Healthcare Limited
Company Overview Aster DM Healthcare Limited
Aster DM Healthcare Limited provides healthcare and allied services in India, the United Arab Emirates, Qatar, Oman, Kingdom of Saudi Arabia, Jordan, Kuwait and Bahrain, and Republic of Mauritius. It operates through Hospitals, Clinics, Retail Pharmacies, and Others segments. The company operates hospitals and in-house pharmacies at the hospitals; and clinics and in-house pharmacies at the clinics, as well as retail pharmacies and optical outlets. It also offers healthcare consultancy and other services. The company was founded in 1987 and is headquartered in Dubai, United Arab Emirates. Address: Tower D - Aspect Tower, Dubai, United Arab Emirates Read Less
Aster DM Healthcare Limited provides healthcare and allied services in India, the United Arab Emirates, Qatar, Oman, Kingdom of Saudi Arabia, Jordan, Kuwait and Bahrain, and Republic of Mauritius. It operates through Hospitals, Clinics, Retail Pharmacies, and Others segments. The...Read More
Frequently Asked Questions About Aster DM Healthcare Limited (ASTERDM:NSE) Stock
Stock Target Advisor's fundamental analysis for Aster DM Healthcare Limited's stock is Neutral.
ASTERDM:NSE stock's dividend yield is 29.54%.
Our analysis grades ASTERDM:NSE stock's dividend yield at A+. This means that ASTERDM:NSE stock's dividend yield is above 100% of the stocks in the Medical Care Facilities sector in the NSE exchange.
Based on this ASTERDM:NSE may be a good dividend stock for its sector.
Unfortunately we do not have enough data on ASTERDM:NSE's stock to indicate what its average analyst target is.
ASTERDM:NSE stock's Price/Earning ratio is 56.89.
Our analysis grades ASTERDM:NSE stock's Price / Earning ratio at F. This means that ASTERDM:NSE stock's Price/Earning ratio is above 43.00000000000001% of the stocks in the Medical Care Facilities sector in the NSE exchange.
Based on this ASTERDM:NSE may be fairly valued for its sector
The last closing price of ASTERDM:NSE's stock was INR 366.00.
The most recent market capitalization for ASTERDM:NSE is INR 184.58B.
Unfortunately we do not have enough analyst data on ASTERDM:NSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Aster DM Healthcare Limited's stock.
As per our most recent records Aster DM Healthcare Limited has 30,330 Employees.
Aster DM Healthcare Limited's registered address is Tower D - Aspect Tower, Dubai, United Arab Emirates.
You can get more information about it from Aster DM Healthcare Limited's website at https://www.asterdmhealthcare.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced on cashflow basis
The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ASTERDM:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
